158 related articles for article (PubMed ID: 9145216)
21. Studies on the first-pass metabolism of ebastine in rats.
Fujii T; Matsumoto S; Hatoyama T; Miyazaki H
Arzneimittelforschung; 1997 Aug; 47(8):949-53. PubMed ID: 9296281
[TBL] [Abstract][Full Text] [Related]
22. Hepatic and intestinal first-pass effects of oltipraz in rats.
Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG
Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
[TBL] [Abstract][Full Text] [Related]
23. Analysis and prediction of absorption profile including hepatic first-pass metabolism of N-methyltyramine, a potent stimulant of gastrin release present in beer, after oral ingestion in rats by gastrointestinal-transit-absorption model.
Kimura T; Iwasaki N; Yokoe JI; Haruta S; Yokoo Y; Ogawara KI; Higaki K
Drug Metab Dispos; 2000 May; 28(5):577-81. PubMed ID: 10772638
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil elastase inhibitor reduces neutrophil chemoattractant production after ischemia-reperfusion in rat liver.
Yamaguchi Y; Akizuki E; Ichiguchi O; Matsumura F; Goto M; Miyanari N; Mori K; Yamada S; Ogawa M
Gastroenterology; 1997 Feb; 112(2):551-60. PubMed ID: 9024309
[TBL] [Abstract][Full Text] [Related]
25. Effect of intestinal first-pass hydrolysis on the oral bioavailability of an ester prodrug of fexofenadine.
Ohura K; Soejima T; Nogata R; Adachi Y; Ninomiya S; Imai T
J Pharm Sci; 2012 Sep; 101(9):3264-74. PubMed ID: 22628163
[TBL] [Abstract][Full Text] [Related]
26. Role of granulocyte elastase in ischemia/reperfusion injury of rat liver.
Kushimoto S; Okajima K; Uchiba M; Murakami K; Harada N; Okabe H; Takatsuki K
Crit Care Med; 1996 Nov; 24(11):1908-12. PubMed ID: 8917044
[TBL] [Abstract][Full Text] [Related]
27. Effect of a specific neutrophil elastase inhibitor, ONO-5046, on endotoxin-induced acute lung injury.
Sakamaki F; Ishizaka A; Urano T; Sayama K; Nakamura H; Terashima T; Waki Y; Tasaka S; Hasegawa N; Sato K; Nakagawa N; Obata T; Kanazawa M
Am J Respir Crit Care Med; 1996 Jan; 153(1):391-7. PubMed ID: 8542148
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of amitriptyline and one of its metabolites, nortriptyline, in rats: little contribution of considerable hepatic first-pass effect to low bioavailability of amitriptyline due to great intestinal first-pass effect.
Bae SK; Yang KH; Aryal DK; Kim YG; Lee MG
J Pharm Sci; 2009 Apr; 98(4):1587-601. PubMed ID: 18780336
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of separate role of intestine and liver in first pass metabolism of budesonide in rat.
Raje AA; Deshpande RD; Pathade VV; Mahajan V; Joshi K; Tambe A; Jinugu R; Madgula VLM; Gaur A; Kandikere V; Patil CR; Mookhtiar KA
Xenobiotica; 2018 Dec; 48(12):1206-1214. PubMed ID: 29165024
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion.
Shimakura A; Kamanaka Y; Ikeda Y; Kondo K; Suzuki Y; Umemura K
Brain Res; 2000 Mar; 858(1):55-60. PubMed ID: 10700596
[TBL] [Abstract][Full Text] [Related]
31. Intestinal first-pass metabolism of eperisone in the rat.
Mihara K; Matsumura M; Yoshioka E; Hanada K; Nakasa H; Ohmori S; Kitada M; Ogata H
Pharm Res; 2001 Aug; 18(8):1131-7. PubMed ID: 11587484
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
Han KS; Lee MG
Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
[TBL] [Abstract][Full Text] [Related]
33. ONO-5046, an elastase inhibitor, attenuates endotoxin-induced acute lung injury in rabbits.
Nishina K; Mikawa K; Takao Y; Maekawa N; Shiga M; Obara H
Anesth Analg; 1997 May; 84(5):1097-103. PubMed ID: 9141938
[TBL] [Abstract][Full Text] [Related]
34. First-pass metabolism of 5-fluorouracil in the perfused rat small intestine.
Gu J; Yuasa H; Hayashi Y; Watanabe J
Biol Pharm Bull; 1998 Aug; 21(8):871-3. PubMed ID: 9743260
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.
Kim SH; Lee MG
Life Sci; 2002 Feb; 70(11):1299-315. PubMed ID: 11883708
[TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal first-pass effect of YJA-20379-8, a new reversible proton pump inhibitor, in rats.
Kim J; Kim EJ; Han KS; Chang MS; Lee MG
J Pharm Pharmacol; 1999 Sep; 51(9):1031-6. PubMed ID: 10528986
[TBL] [Abstract][Full Text] [Related]
37. Stereoselective first-pass metabolism of verapamil in the small intestine and liver in rats.
Hanada K; Ikemi Y; Kukita K; Mihara K; Ogata H
Drug Metab Dispos; 2008 Oct; 36(10):2037-42. PubMed ID: 18617604
[TBL] [Abstract][Full Text] [Related]
38. Effects of a novel elastase inhibitor, ONO-5046, on nephrotoxic serum nephritis in rats.
Suzuki S; Gejyo F; Kuroda T; Kazama JJ; Imai N; Kimura H; Arakawa M
Kidney Int; 1998 May; 53(5):1201-8. PubMed ID: 9573534
[TBL] [Abstract][Full Text] [Related]
39. In vivo assessment of intestinal, hepatic, and pulmonary first pass metabolism of propofol in the rat.
Raoof AA; Augustijns PF; Verbeeck RK
Pharm Res; 1996 Jun; 13(6):891-5. PubMed ID: 8792428
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil elastase inhibitor, ONO-5046, modulates acid-induced lung and systemic injury in rabbits.
Kaneko K; Kudoh I; Hattori S; Yamada H; Ohara M; Wiener-Kronish J; Okumura F
Anesthesiology; 1997 Sep; 87(3):635-41. PubMed ID: 9316970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
